Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $187,984 | 6 | 96.0% |
| Food and Beverage | $5,590 | 293 | 2.9% |
| Travel and Lodging | $1,168 | 3 | 0.6% |
| Consulting Fee | $800.00 | 1 | 0.4% |
| Education | $373.41 | 6 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Nielsen BioSciences, Inc. | $138,804 | 1 | $0 (2024) |
| Bausch Health US, LLC | $49,180 | 5 | $0 (2019) |
| LEO Pharma AS | $1,168 | 3 | $0 (2017) |
| ABBVIE INC. | $1,046 | 55 | $0 (2024) |
| Almirall LLC | $855.13 | 4 | $0 (2023) |
| Galderma Laboratories, L.P. | $665.59 | 16 | $0 (2022) |
| Janssen Biotech, Inc. | $640.31 | 28 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $506.76 | 22 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $397.92 | 21 | $0 (2024) |
| Lilly USA, LLC | $384.40 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $140,196 | 65 | Nielsen BioSciences, Inc. ($138,804) |
| 2023 | $1,495 | 80 | AbbVie Inc. ($328.67) |
| 2022 | $819.99 | 38 | ABBVIE INC. ($299.93) |
| 2021 | $869.84 | 5 | Almirall LLC ($816.51) |
| 2020 | $136.52 | 3 | Galderma Laboratories, L.P. ($85.42) |
| 2019 | $43,406 | 26 | Bausch Health US, LLC ($42,930) |
| 2018 | $6,724 | 32 | Bausch Health US, LLC ($6,250) |
| 2017 | $2,269 | 60 | LEO Pharma AS ($1,168) |
All Payment Transactions
309 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Dermatology | ||||||
| 12/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $21.25 | General |
| Category: Dermatology | ||||||
| 12/10/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Immunology | ||||||
| 12/05/2024 | Lilly USA, LLC | — | Food and Beverage | Cash or cash equivalent | $51.87 | General |
| 12/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $22.95 | General |
| Category: Immunology | ||||||
| 12/04/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Dermatology | ||||||
| 11/30/2024 | Nielsen BioSciences, Inc. | Candin (Biological) | — | Cash or cash equivalent | $138,804.04 | Research |
| Study: CFW-3A • Category: Immunotherapy | ||||||
| 11/21/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $26.26 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPEVIGO (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Immunology | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $27.03 | General |
| Category: Immunology | ||||||
| 11/04/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.21 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $24.25 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: Immunology | ||||||
| 09/17/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $27.09 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: Inflammation | ||||||
| 08/22/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $16.61 | General |
| Category: DERMATOLOGY | ||||||
| 08/20/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.97 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: IMMUNOLOGY | ||||||
| 07/23/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $28.84 | General |
| Category: Immunology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CFW-3A | Nielsen BioSciences, Inc. | $138,804 | 1 |
| A PHASE 1B OPEN-LABEL STUDY EVALUATING THE ABSORPTION AND SYSTEMIC PHARMACOKINETICS OF TOPICALLY APPLIED IDP-126 GEL IN COMPARISON WITH EPIDUO FORTE GEL IN SUBJECTS WITH MODERATE TO SEVERE ACNE VULGARIS UNDER MAXIMAL USE CONDITIONS | Bausch Health US, LLC | $42,930 | 3 |
| A Phase 1b Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison with EpiDuo Forte Gel 0.3 adapalene2.5 BPO in Subjects with Acne Vulgaris under Maximal Use Conditions | Bausch Health US, LLC | $6,250 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 2,468 | 4,631 | $690,313 | $179,751 |
| 2022 | 20 | 2,478 | 4,684 | $671,982 | $173,841 |
| 2021 | 20 | 2,355 | 4,384 | $591,372 | $170,397 |
| 2020 | 23 | 2,274 | 4,100 | $583,165 | $151,399 |
All Medicare Procedures & Services
84 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 105 | 172 | $19,780 | $6,647 | 33.6% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 269 | 1,502 | $16,522 | $6,609 | 40.0% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 154 | 176 | $16,896 | $6,072 | 35.9% |
| 12052 | Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2021 | 16 | 18 | $11,628 | $4,221 | 36.3% |
| 11602 | Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2021 | 37 | 46 | $24,978 | $4,136 | 16.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 31 | 31 | $7,347 | $2,082 | 28.3% |
| 11642 | Removal of malignant growth (1.1 to 2.0 centimeters) of the face, ears, eyelids, nose, or lips | Office | 2021 | 17 | 19 | $11,305 | $1,579 | 14.0% |
| 11104 | Punch biopsy of single skin lesion | Office | 2021 | 13 | 14 | $3,752 | $994.88 | 26.5% |
| 69100 | Biopsy of ear | Office | 2021 | 12 | 15 | $3,285 | $598.11 | 18.2% |
| 11900 | Injection of up to 7 skin growths | Office | 2021 | 13 | 16 | $1,968 | $304.96 | 15.5% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 15 | 27 | $108.00 | $18.46 | 17.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 328 | 347 | $82,239 | $23,924 | 29.1% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 248 | 312 | $66,456 | $19,243 | 29.0% |
| 17000 | Destruction of skin growth | Office | 2020 | 325 | 492 | $70,848 | $16,487 | 23.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 234 | 317 | $50,720 | $13,960 | 27.5% |
| 12032 | Repair of wound (2.6 to 7.5 centimeters) of the scalp, underarms, trunk, arms, and/or legs | Office | 2020 | 39 | 48 | $31,632 | $10,500 | 33.2% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 99 | 114 | $27,588 | $8,602 | 31.2% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2020 | 186 | 363 | $72,600 | $8,381 | 11.5% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 53 | 71 | $22,436 | $7,670 | 34.2% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 104 | 183 | $20,815 | $6,717 | 32.3% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2020 | 39 | 47 | $18,048 | $5,724 | 31.7% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 241 | 1,324 | $14,553 | $5,374 | 36.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 169 | 201 | $19,296 | $5,238 | 27.1% |
| 12052 | Repair of wound (2.6 to 5.0 centimeters) of face, ears, eyelids, nose, lips, and/or mouth | Office | 2020 | 16 | 18 | $11,628 | $4,236 | 36.4% |
| 11602 | Removal of malignant growth (1.1 to 2.0 centimeters) of the trunk, arms, or legs | Office | 2020 | 30 | 43 | $23,113 | $3,490 | 15.1% |
About Dr. Jess Demaria, MD
Dr. Jess Demaria, MD is a Dermatology healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1154373009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jess Demaria, MD has received a total of $195,915 in payments from pharmaceutical and medical device companies, with $140,196 received in 2024. These payments were reported across 309 transactions from 35 companies. The most common payment nature is "" ($187,984).
As a Medicare-enrolled provider, Demaria has provided services to 9,575 Medicare beneficiaries, totaling 17,799 services with total Medicare billing of $675,387. Data is available for 4 years (2020–2023), covering 84 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Westerville, OH
- Active Since 05/17/2006
- Last Updated 05/01/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1154373009
Products in Payments
- Candin (Biological) $138,804
- Klisyri (Drug) $838.62
- RINVOQ (Biological) $519.14
- Sotyktu (Drug) $482.07
- SKYRIZI (Biological) $399.71
- EUCRISA (Drug) $345.16
- TALTZ (Drug) $314.78
- EPIDUO FORTE (Drug) $274.33
- TREMFYA (Drug) $266.05
- ILUMYA (Biological) $251.77
- OPZELURA (Drug) $239.55
- STELARA (Biological) $233.41
- DUPIXENT (Biological) $200.39
- SOOLANTRA (Drug) $162.10
- SPEVIGO (Drug) $142.12
- ORACEA (Drug) $132.06
- EPSOLAY (Drug) $97.10
- VTAMA (Drug) $93.31
- Tremfya (Drug) $89.95
- COSENTYX (Biological) $83.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Westerville
Dr. Joshua Grosshandler, M.d, M.D
Dermatology — Payments: $378,447
Dr. Brittany Dulmage, M.d, M.D
Dermatology — Payments: $18,054
Rosina Lin, M.d, M.D
Dermatology — Payments: $17,300
Dr. Kevin Karikomi, D.o, D.O
Dermatology — Payments: $14,525
Jennifer Nash, M.d, M.D
Dermatology — Payments: $9,506
Sara Huff, Md, MD
Dermatology — Payments: $5,661